Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Sanders

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Virchows Archiv : an International Journal of Pathology|June 27, 2025
Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of gradingOliver Hommerding, Fereschte Sara Rejai, Anna Scherping, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2025
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine TumorsBarbara Kreppel, Jana Fink, Christine Sanders, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 2024
Peer-to-peer validation of Ki-67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?Marit Bernhardt, Leonie Weinhold, Christine Sanders, et al.
Journal of Cancer Research and Clinical Oncology|September 28, 2024
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infectionThomas Zeyen, Lea L Friker, Daniel Paech, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
Molecular Cancer Therapeutics|July 9, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in CholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Molecular Cancer Therapeutics|June 13, 2025
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Virchows Archiv : an International Journal of Pathology|June 27, 2025
Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of gradingOliver Hommerding, Fereschte Sara Rejai, Anna Scherping, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 2025
Prognostic Significance of CD68+ Macrophages and FoxP3+ Regulatory T Cells in Neuroendocrine TumorsBarbara Kreppel, Jana Fink, Christine Sanders, et al.
Oncotarget|April 16, 2016
MERTK as a novel therapeutic target in head and neck cancerAnne von Mässenhausen, Christine Sanders, Britta Thewes, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 2024
Peer-to-peer validation of Ki-67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?Marit Bernhardt, Leonie Weinhold, Christine Sanders, et al.
Journal of Cancer Research and Clinical Oncology|September 28, 2024
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infectionThomas Zeyen, Lea L Friker, Daniel Paech, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate CancerJohannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
Molecular Cancer Therapeutics|July 9, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in CholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Molecular Cancer Therapeutics|June 13, 2025
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinomaRacha Hosni, Niklas Klümper, Christine Sanders, et al.
Pageof 2